Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits

Journal of Neuroscience

Volumn 33, Issue 15, 2013, Pages 6350-6366

  Subbanna, Shivakumar ^a   Shivakumar, Madhu ^a   Psychoyos, Delphine ^b   Xie, Shan ^a   Basavarajappa, Balapal S ^a,c,d  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ALCOHOL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHATIDYLETHANOLAMINE; PHOSPHODIESTERASE; PHOSPHOLIPASE D; PROTEIN KINASE B; TAU PROTEIN; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; AMIDE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID RECEPTOR ANTAGONIST; ENDOCANNABINOID; GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE; N ACYLPHOSPHATIDYLETHANOLAMINE PHOSPHOLIPASE D, MOUSE; N-ACYLPHOSPHATIDYLETHANOLAMINE PHOSPHOLIPASE D, MOUSE; NERVE PROTEIN; NEUROPROTECTIVE AGENT; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; RIMONABANT;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; LONG TERM POTENTIATION; MALE; MASS SPECTROMETRY; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYNAPSE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BRAIN; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MEMORY DISORDER; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION;

ANIMALS; ANIMALS, NEWBORN; ARACHIDONIC ACIDS; BRAIN; CANNABINOID RECEPTOR ANTAGONISTS; ENDOCANNABINOIDS; ETHANOL; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCERIDES; MALE; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; PHOSPHOLIPASE D; PHOSPHORIC DIESTER HYDROLASES; PHOSPHORYLATION; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; SYNAPSES;

MLCS; MLOWN;

EID: 84876070411     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3786-12.2013     Document Type: Article

References (102)

1. Alexinsky T, Chapoutier G (1978) A new behavioral model for studying delayed response in rats. Behav Biol 24:442-456.
2. Bacci A, Huguenard JR, Prince DA (2004) Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431: 312-316.
3. Basavarajappa BS (2007a) Critical enzymes involved in endocannabinoid metabolism. Protein Pept Lett 14:237-246.
4. Basavarajappa BS (2007b) The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism. Mini Rev Med Chem 7:769-779.
5. Basavarajappa BS (2007c) Endocannabinoid signaling and alcohol addiction. In: New research on alcoholism (Baye DR, ed), pp 1-55. New York: Nova Science Publishers.
6. Basavarajappa BS (2007d) Neuropharmacology of the endocannabinoid signaling system: molecular mechanisms, biological actions and synaptic plasticity. CurrNeuropharmaco 5:81-97.
7. Basavarajappa BS, Hungund BL (1999) Chronic ethanol increases the can-nabinoid receptor agonist, anandamide and its precursor N-arachidonyl phosphatidyl ethanolamine in SK-N-SH Cells. J Neurochem 72:522-528.
8. 35S]guanosine triphosphateyS binding in the brain of C57BL/6 and DBA/2 mice. J Neurosci Res 64:429-436.
9. Basavarajappa BS, Saito M, Cooper TB, Hungund BL (2003) Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. Eur J Pharmacol 466:73-83.
10. Basavarajappa BS, Yalamanchili R, Cravatt BF, Cooper TB, Hungund BL (2006) Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice. Neuropharmacology 50:834-844.
11. Basavarajappa BS, Ninan I, Arancio O (2008) Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. J Neurochem 107:1001-1013.
12. Basavarajappa BS, Nixon RA, Arancio O (2009) Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration. Mini Rev Med Chem 9:448-462.
13. Bayer SA, Altman J, Russo RJ, Zhang X (1993) Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14:83-144.
14. Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, Urban GM, Monory K, Marsicano G, Matteoli M, Canty A, Irving AJ, Katona I, Yana-gawa Y, Rakic P, Lutz B, Mackie K, Harkany T (2007) Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science 316:1212-1216.
15. Bernard C, Milh M, Morozov YM, Ben-Ari Y, Freund TF, Gozlan H (2005) Altering cannabinoid signaling during development disrupts neuronal activity. Proc Natl Acad Sci USA 102:9388-9393.
16. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Gangadharan U, Hobbs C, Di Marzo V, Doherty P (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163:463-468.
17. Bohme GA, Laville M, Ledent C, Parmentier M, Imperato A (2000) Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience 95:5-7.
18. Campolongo P, Trezza V, Ratano P, Palmery M, Cuomo V (2011) Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology (Berl) 214:5-15.
19. Chakraborty G, Saito M, Mao RF, Wang R, Vadasz C, Saito M (2008) Lithium blocks ethanol-induced modulation of protein kinases in the developing brain. Biochem Biophys Res Commun 367:597-602.
20. Colombo G, Agabio R, F a M, Guano L, Lobina C, Loche A, Reali R, Gessa GL (1998) Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol Alcohol 33:126-130.
21. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83-87.
22. De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V (1998) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA 95:8375-8380.
23. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Pio-melli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691.
24. Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res 31:47-59.
25. Fernández-Ruiz J, Berrendero F, Hernández ML, Ramos JA (2000) The endogenous cannabinoid system and brain development. Trends Neurosci 23:14-20.
26. Fernández-Ruiz J, Gómez M, Hernández M, de Miguel R, Ramos JA (2004) Cannabinoids and gene expression during brain development. Neurotox Res 6:389-401.
27. Gaffan D, Saunders RC, Gaffan EA, Harrison S, Shields C, Owen MJ (1984) Effects of fornix transection upon associative memory in monkeys: role of the hippocampus in learned action. Q J Exp Psychol B 36:173-221.
28. Galindo R, Zamudio PA, Valenzuela CF (2005) Alcohol is a potent stimulant of immature neuronal networks: implications for fetal alcohol spectrum disorder. J Neurochem 94:1500-1511.
29. Galve-Roperh I, Sánchez C, Cortés ML, Gómez del Pulgar T, Izquierdo M, Guzmán M (2000) Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 6:313-319.
30. Gil-Mohapel J, Boehme F, Kainer L, Christie BR (2010) Hippocampal cell loss and neurogenesis after fetal alcohol exposure: insights from different rodent models. Brain Res Rev 64:283-303.
31. Giuffrida A, Parsons LH, Kerr TM, Rodríguez de Fonseca F, Navarro M, Piomelli D (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358-363.
32. Goodman AM, Delis DC, Mattson SN (1999) Normative data for 4-year-old children on the California Verbal Learning Test-Children's Version. Clin Neuropsychol 13:274-282.
33. Grossmann J (2002) Molecular mechanisms of "detachment-induced apoptosis-Anoikis." Apoptosis 7:247-260.
34. Guo W, Crossey EL, Zhang L, Zucca S, George OL, Valenzuela CF, Zhao X (2011) Alcohol exposure decreases CREB binding protein expression and histone acetylation in the developing cerebellum. PloS One 6:e19351.
35. Hampson RE, Miller F, Palchik G, Deadwyler SA (2011) Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity. Neuropharmacology 60:944-952.
36. Hansen HH, Krutz B, Sifringer M, Stefovska V, Bittigau P, Pragst F, Marsi-cano G, Lutz B, Ikonomidou C (2008) Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity. Ann Neurol 64:42-52.
37. Harkany T, Keimpema E, Barabás K, Mulder J (2008) Endocannabinoid functions controlling neuronal specification during brain development. Mol Cell Endocrinol 286:S84-S90.
38. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87:1932-1936.
39. Howlett AC, Qualy JM, Khachatrian LL (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 29:307-313.
40. Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677-736.
41. Huston JP, Mondadori C, Waser PG (1974) Facilitation of learning by reward post-trial memory processes. Experientia 30:1038-1040.
42. Ikonomidou C, Stefovska V, Turski L (2000a) Neuronal death enhanced by N-methyl-D-aspartate antagonists. Proc Natl Acad Sci U S A 97:12885-12890.
43. Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, Price MT, Stefovska V, Hörster F, Tenkova T, Dikranian K, Olney JW (2000b) Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287:1056-1060.
44. Ikonomidou C, Bittigau P, Koch C, Genz K, Hoerster F, Felderhoff-Mueser U, Tenkova T, Dikranian K, Olney JW (2001) Neurotransmitters and apoptosisin the developing brain. Biochem Pharmacol 62:401-405.
45. Izumi Y, Kitabayashi R, Funatsu M, Izumi M, Yuede C, Hartman RE, Wozniak DF, Zorumski CF (2005) A single day of ethanol exposure during development has persistent effects on bi-directional plasticity, N-methyl-D-aspartate receptor function and ethanol sensitivity. Neuro-science 136:269-279.
46. Jacob C, Christen CN, Pereira JA, Somandin C, Baggiolini A, Lötscher P, Ozçelik M, Tricaud N, Meijer D, Yamaguchi T, Matthias P, Suter U (2011) HDAC1 and HDAC2 control the transcriptional program of my-elination and the survival of Schwann cells. Nat Neurosci 14:429-436.
47. Jaffard R, Dubois M, Galey D (1981) Memory of a choice direction in a T-maze as measured by spontaneous alternation in mice: effects of inter-trial interval and reward. Behav Proc 6:11-21.
48. Ketty SS (1976) Neural mechanisms of learning and memory. In: Biological concomitants of affective states and their possible role in memory processes (Rosenzweig M, Bennett EL, eds), pp 321-326. Cambridge, MA: Massachusetts Institute of Technology.
49. Kim D, Thayer SA (2001) Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. J Neurosci 21:RC146(1-5).
50. Lallemand F, de Witte P (2005) Ethanol induces higher BEC in CB1 cannabinoid receptor knockout mice while decreasing ethanol preference. Alcohol Alcohol 40:54-62.
51. Leung D, Saghatelian A, Simon GM, Cravatt BF (2006) Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45: 4720-4726.
52. Livy DJ, Miller EK, Maier SE, West JR (2003) Fetal alcohol exposure and temporal vulnerability: effects of binge-like alcohol exposure on the developing rat hippocampus. Neurotoxicol Teratol 25:447-458.
53. Lubin FD, Sweatt JD (2007) The IkappaB kinase regulates chromatin structure during reconsolidation of conditioned fear memories. Neuron 55: 942-957.
54. Luikart BW, Zhang W, Wayman GA, Kwon CH, Westbrook GL, Parada LF (2008) Neurotrophin-dependent dendritic filopodial motility: a convergence on PI3K signaling. J Neurosci 28:7006-7012.
55. Lundquist F (1959) The determination of ethyl alcohol in blood and tissue. Methods Biochem Anal 7:217-251.
56. Mameli M, Zamudio PA, Carta M, Valenzuela CF (2005) Developmentally regulated actions of alcohol on hippocampal glutamatergic transmission. J Neurosci 25:8027-8036.
57. Marushige K, Marushige Y (1999) Changes in the mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling associated with the induction of apoptosis. Anticancer Res 19:3865-3871.
58. Mato S, Del Olmo E, Pazos A (2003) Ontogenetic development of cannabi-noid receptor expression and signal transduction functionality in the human brain. Eur J Neurosci 17:1747-1754.
59. Mattson SN, Riley EP (1998) A review of the neurobehavioral deficits in children with fetal alcohol syndrome or prenatal exposure to alcohol. Alcohol Clin Exp Res 22:279-294.
60. Mattson SN, Riley EP, Gramling L, Delis DC, Jones KL (1998) Neuropsychological comparison of alcohol-exposed children with or without physical features of fetal alcohol syndrome. Neuropsychology 12:146-153.
61. Mattson SN, Goodman AM, Caine C, Delis DC, Riley EP (1999) Executive functioning in children with heavy prenatal alcohol exposure. Alcohol Clin Exp Res 23:1808-1815.
62. Mattson SN, Crocker N, Nguyen TT (2011) Fetal alcohol spectrum disorders: neuropsychological and behavioral features. Neuropsychol Rev 21: 81-101.
63. May PA, Gossage JP, Kalberg WO, Robinson LK, Buckley D, Manning M, Hoyme HE (2009) Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies. Dev Disabil Res Rev 15:176-192.
64. Mechoulam R, Parker LA (2013) The endocannabinoid system and the brain. Annu Rev Psychol 64:21-47.
65. Medina AE (2011) Fetal alcohol spectrum disorders and abnormal neuronal plasticity. Neuroscientist 17:274-287.
66. Morishita J, Okamoto Y, Tsuboi K, Ueno M, Sakamoto H, Maekawa N, Ueda N (2005) Regional distribution and age-dependent expression of N-acylphosphatidylethanolamine-hydrolyzing phospholipase D in rat brain. J Neurochem 94:753-762.
67. Morozov YM, Freund TF (2003) Postnatal development and migration of cholecystokinin-immunoreactive interneurons in rat hippocampus. Neuroscience 120:923-939.
68. Morozov YM, Ben-Ari Y, Freund TF (2004) The spatial and temporal pattern of fatty acid amide hydrolase expression in rat hippocampus during postnatal development. Eur J Neurosci 20:459-466.
69. Mulder J, Aguado T, Keimpema E, Barabás K, Ballester Rosado CJ, Nguyen L, Monory K, Marsicano G, Di Marzo V, Hurd YL, Guillemot F, Mackie K, Lutz B, Guzmán M, Lu HC, Galve-Roperh I, Harkany T (2008) Endo-cannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc Natl Acad Sci U S A 105:8760-8765.
70. Nyilas R, Dudok B, Urbán GM, Mackie K, Watanabe M, Cravatt BF, Freund TF, Katona I (2008) Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals. J Neurosci 28:1058-1063.
71. Ohno-Shosaku T, Maejima T, Kano M (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to pre-synaptic terminal. Neuron 29:729-738.
72. Olney JW, Tenkova T, Dikranian K, Qin YQ, Labruyere J, Ikonomidou C (2002) Ethanol-induced apoptotic neurodegeneration in the developing C57BL/6 mouse brain. Brain Res Dev Brain Res 133:115-126.
73. Pava MJ, Woodward JJ (2012) A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research. Alcohol 46:185-204.
74. Petkov VD, Konstantinova ER, Petkov VV, Vaglenova JV (1991) Learning and memoryinrats exposed pre- and postnatallytoalcohol. Anattempt at pharmacological control. Methods Find Exp Clin Pharmacol 13:43-50.
75. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873-884.
76. Psychoyos D, Vinod KY, Cao J, Xie S, Hyson RL, Wlodarczyk B, He W, Cooper TB, Hungund BL, Finnell RH (2012) Cannabinoid receptor 1 signaling in embryo neurodevelopment. Birth defects research Part B, Developmental and reproductive toxicology 95:137-150.
77. Puighermanal E, Marsicano G, Busquets-Garcia A, Lutz B, Maldonado R, Ozaita A (2009) Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci 12:1152-1158.
78. Puzzo D, Staniszewski A, Deng SX, Privitera L, Leznik E, Liu S, Zhang H, Feng Y, Palmeri A, Landry DW, Arancio O (2009) Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model. J Neurosci 29:8075-8086.
79. Reibaud M, Obinu MC, Ledent C, Parmentier M, Böhme GA, Imperato A (1999) Enhancement of memory in cannabinoid CB1 receptor knockout mice. Eur J Pharmacol 379:R1-R2.
80. Sadrian B, Subbanna S, Wilson DA, Basavarajappa BS, Saito M (2012) Lithium prevents long-term neural and behavioral pathology induced byearly alcohol exposure. Neuroscience 206:122-135.
81. Schneider M (2009) Cannabis use in pregnancy and early life and its consequences: animal models. Eur Arch Psychiatry Clin Neurosci 259:383-393.
82. Sik A, van Nieuwehuyzen P, Prickaerts J, Blokland A (2003) Performance of different mouse strains in an object recognition task. Behav Brain Res 147:49-54.
83. Simon GM, Cravatt BF (2010) Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contributetoendocannabinoid productioninvivo. Mol Biosyst 6:1411-1418.
84. Starowicz K, Nigam S, Di Marzo V (2007) Biochemistry and pharmacology of endovanilloids. Pharmacol Ther 114:13-33.
85. Stefanis NC, Delespaul P, Henquet C, Bakoula C, Stefanis CN, Van Os J (2004) Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 99:1333-1341.
86. Subbanna S, Shivakumar M, Umapathy NS, Saito M, Mohan PS, Kumar A, Nixonc RA, Verin AD, Psychoyos D, Basavarajappa BS (2013) G9a-mediated histone methylation regulates ethanol-induced neurodegeneration in the neonatal mouse brain. Neurobiol Dis. Advance online publication. Retrieved March 10, 2013. doi:10.1016/j.nbd.2013.01.022.
87. Tsou K, Brown S, Sañudo-Peña MC, Mackie K, Walker JM (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393-411.
88. Tsuboi K, Okamoto Y, Ikematsu N, Inoue M, Shimizu Y, Uyama T, Wang J, Deutsch DG, Burns MP, Ulloa NM, Tokumura A, Ueda N (2011) Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmal-ogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways. Biochim Biophys Acta 1811:565-577.
89. Twitchell W, Brown S, Mackie K (1997) Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neuro-physiol 78:43-50.
90. Vaglenova J, Pandiella N, Wijayawardhane N, Vaithianathan T, Birru S, Breese C, Suppiramaniam V, Randal C (2008) Aniracetam reversed learning and memory deficits following prenatal ethanol exposure by modulating functions of synaptic AMPA receptors. Neuropsychophar-macology 33:1071-1083.
91. Vinod KY, Arango V, Xie S, Kassir SA, Mann JJ, Cooper TB, Hungund BL (2005) Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims. Biol Psychiatry 57:480-486.
92. Vitalis T, Laine ́ J, Simon A, Roland A, Leterrier C, Lenkei Z (2008) The type 1 cannabinoid receptor is highly expressed in embryonic cortical projection neurons and negatively regulates neurite growth in vitro. Eur J Neu-rosci 28:1705-1718.
93. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M (2002) Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci U S A 99:13217-13221.
94. Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G (2003) Endocan-nabinoid signaling via CB1 receptors is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci U S A 100: 1393-1398.
95. Wang X, Dow-Edwards D, Anderson V, Minkoff H, Hurd YL (2006) Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use. Pharmacogenomics J 6:255-264.
96. Wilson DA, Peterson J, Basavaraj BS, Saito M (2011) Local and regional network function in behaviorally relevant cortical circuits of adult mice following postnatal alcohol exposure. Alcohol Clin Exp Res 35: 1974-1984.
97. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588-592.
98. Worster DT, Schmelzle T, Solimini NL, Lightcap ES, Millard B, Mills GB, Brugge JS, Albeck JG (2012) Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2. Sci Signal 5:ra19.
99. Wu CS, Jew CP, Lu HC (2011) Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. Future Neurol 6:459-480.
100. Young C, Straiko MM, Johnson SA, Creeley C, Olney JW (2008) Ethanol causes and lithium prevents neuroapoptosis and suppression of pERK in the infant mouse brain. Neurobiol Dis 31:355-360.
101. Zhou FC, Sari Y, Zhang JK, Goodlett CR, Li T (2001) Prenatal alcohol exposure retards the migration and development of serotonin neurons in fetal C57BL mice. Brain Res Dev Brain Res 126:147-155.
102. Zhou FC, Sari Y, Powrozek TA (2005) Fetal alcohol exposure reduces serotonin innervation and compromises development of the forebrain along the serotonergic pathway. Alcohol Clin Exp Res 29:141-149.